16 September 2024
Kromek Group
plc
("Kromek"
or the "Group")
Kromek awarded £2.0m contract from UK
Ministry of Defence
Kromek (AIM: KMK), a leading developer
of radiation and bio-detection technology solutions for the
advanced imaging and CBRN detection segments, is pleased to
announce that it has been awarded a contract worth £2.0m by the UK
Ministry of Defence ("MOD") for the supply of nuclear radiation
detectors and ancillary products. The contract is to be delivered
in the Group's current financial year ending 30 April 2025.
The contract, which was awarded after a
competitive tender process, is for the supply of the Group's D5
RIID, a handheld, highly-sensitive gamma and neutron detector,
along with the Group's Alpha Beta probe attachment and other
associated products. Launched in November 2023, the Alpha Beta
probe connects directly to the D5 RIID to enable alpha and beta
radiation to be detected, allowing the single, small form factor
upgraded device to detect all types of radioactive material.
Arnab Basu,
CEO of Kromek, said: "We are delighted to have
won this important contract from the UK MOD, which is a significant
strategic customer for Kromek. That it was awarded after a rigorous
tender process provides excellent endorsement of the strength of
our solution. It is also great validation to receive this key order
for our Alpha Beta probe so soon after its launch at the end of
last year. With the Alpha Beta probe upgrade, our D5 RIID is one of
the most versatile handheld radiation detectors available
today. We are looking forward to delivering this contract and
supporting UK national defence efforts and to continuing to
strengthen our relationship with this important customer."
For
further information, please contact:
|
Kromek Group
plc
|
|
|
Arnab Basu, CEO
Paul Farquhar,
CFO
|
+44 (0)1740 626 060
|
|
|
|
|
Cavendish Capital Markets Limited (Nominated Adviser and
Broker)
|
|
|
Geoff Nash/Giles Balleny/Seamus
Fricker - Corporate Finance
Tim Redfern - ECM
|
+44 (0)20
7220 0500
|
|
Michael Johnson/Tamar Cranford-Smith - Sales
|
|
|
Gracechurch Group
(Financial PR)
|
|
|
Harry Chathli/Claire Norbury/Henry Gamble
|
+44 (0)20 4582 3500
|
Kromek Group
plc
Kromek Group plc is a leading developer of radiation
detection and bio-detection technology solutions for the advanced
imaging and CBRN detection segments. Headquartered in County
Durham, UK, Kromek has manufacturing operations in the UK and US,
delivering on the vision of enhancing the quality of life through
innovative detection technology
solutions.
The advanced imaging segment comprises the medical,
security and industrial markets. Kromek provides its OEM customers
with detector components, based on its core cadmium zinc telluride
(CZT) platform, to enable better detection of diseases such as
cancer and Alzheimer's, contamination in industrial manufacture and
explosives in aviation settings.
In CBRN detection, the Group provides nuclear
radiation detection solutions to the global homeland defense and
security market. Kromek's compact, handheld, high-performance
radiation detectors, based on advanced scintillation technology,
are primarily used to protect critical infrastructure and urban
environments from the threat of 'dirty
bombs'.
The Group is also developing bio-security solutions
in the CBRN detection segment. These consist of fully automated and
autonomous systems to detect a wide range of airborne
pathogens.
Kromek is listed on AIM, a market of the London Stock
Exchange, under the trading symbol
'KMK'.
Further information is available at
www.kromek.com.